Patents by Inventor Jeremy Boydston

Jeremy Boydston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20030095971
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: October 30, 2001
    Publication date: May 22, 2003
    Applicant: Corixa Corporation
    Inventors: Alexander Gaiger, Patricia D. McNeill, Molly Smithgall, Gus Moulton, Thomas S. Vedvick, Paul R. Sleath, Sally P. Mossman, Lawrence S. Evans, A. Gregory Spies, Jeremy Boydston
  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20030072767
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: August 24, 2001
    Publication date: April 17, 2003
    Inventors: Alexander Gaiger, Patricia D. McNeill, Molly Smithgall, Gus Moulton, Thomas S. Vedvick, Paul R. Sleath, Sally Mossman, Lawrence Evans, A. Gregory Spies, Jeremy Boydston